Xarelto® Lawsuits Consolidated in Louisiana
January 6th, 2015|
Xarelto® is a blood thinner once lauded as a revolutionary treatment for stroke and heart attack victims because it required less monitoring by medical staff. However, the drug was found to increase the risk of uncontrolled bleeding in certain patients.
Some bleeding injury victims have gone on to file Xarelto lawsuits against Johnson & Johnson, the maker of the drug. And now these cases have taken another step forward in the legal process.
Injury Lawyer News reports that a judicial panel has decided the Xarelto lawsuits should be consolidated. This means the roughly 21 Xarelto lawsuits filed in as many as 10 federal courts will be examined during a single trial in the Eastern District of Louisiana with U.S. District Judge Eldon E. Fallon presiding.
The cases were consolidated after it was determined that each of the lawsuits were based on claims. Attorneys for Xarelto injury victims argue Johnson & Johnson failed to provide enough warning of the dangers associated with the bleeding risks posed to users.
At Ferrer, Poirot & Wansbrough, we know the struggles Xarelto drug injury victims are facing, and our drug injury lawyers are here to help if you or a loved one was the victim of a Xarelto bleeding injury. Dial (800) 210-8503 to contact our 24/7 legal team now.